CN102558160B - 4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 - Google Patents
4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 Download PDFInfo
- Publication number
- CN102558160B CN102558160B CN201010596397.7A CN201010596397A CN102558160B CN 102558160 B CN102558160 B CN 102558160B CN 201010596397 A CN201010596397 A CN 201010596397A CN 102558160 B CN102558160 B CN 102558160B
- Authority
- CN
- China
- Prior art keywords
- base
- toluidrin
- quinazoline
- amino
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010596397.7A CN102558160B (zh) | 2010-12-20 | 2010-12-20 | 4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010596397.7A CN102558160B (zh) | 2010-12-20 | 2010-12-20 | 4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102558160A CN102558160A (zh) | 2012-07-11 |
CN102558160B true CN102558160B (zh) | 2015-09-23 |
Family
ID=46404913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010596397.7A Expired - Fee Related CN102558160B (zh) | 2010-12-20 | 2010-12-20 | 4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102558160B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1187129A (zh) * | 1995-06-06 | 1998-07-08 | 罗纳·布朗克罗尔药制品有限公司 | 具有选择性抑制her-2自磷酸化性质的蛋白质酪氨酸激酶芳基和杂芳基喹唑啉化合物 |
CN1211239A (zh) * | 1996-02-13 | 1999-03-17 | 曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
CN1292788A (zh) * | 1998-01-12 | 2001-04-25 | 葛兰素集团有限公司 | 作为蛋白酪氨酸激酶抑制剂的二环杂芳族化合物 |
CN1882576A (zh) * | 2003-09-16 | 2006-12-20 | 阿斯特拉曾尼卡有限公司 | 喹唑啉衍生物 |
-
2010
- 2010-12-20 CN CN201010596397.7A patent/CN102558160B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1187129A (zh) * | 1995-06-06 | 1998-07-08 | 罗纳·布朗克罗尔药制品有限公司 | 具有选择性抑制her-2自磷酸化性质的蛋白质酪氨酸激酶芳基和杂芳基喹唑啉化合物 |
CN1211239A (zh) * | 1996-02-13 | 1999-03-17 | 曾尼卡有限公司 | 作为vegf抑制剂的喹唑啉衍生物 |
CN1292788A (zh) * | 1998-01-12 | 2001-04-25 | 葛兰素集团有限公司 | 作为蛋白酪氨酸激酶抑制剂的二环杂芳族化合物 |
CN1882576A (zh) * | 2003-09-16 | 2006-12-20 | 阿斯特拉曾尼卡有限公司 | 喹唑啉衍生物 |
Also Published As
Publication number | Publication date |
---|---|
CN102558160A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103664892B (zh) | 喹啉衍生物的结晶 | |
CN105753872B (zh) | 二螺吡咯烷衍生物 | |
JP5202302B2 (ja) | 医薬組成物 | |
CN102643268B (zh) | 喹啉类及噌啉类化合物及其应用 | |
AU2016247044A1 (en) | C-met modulator pharmaceutical compositions | |
CN105001208A (zh) | 一种表皮生长因子受体egfr抑制剂及其制备方法与用途 | |
CN110283052A (zh) | 由白藜芦醇与蛋白激酶抑制剂构成的共晶复合物以及含有该共晶复合物的组合物 | |
CN102731485A (zh) | 4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途 | |
CN107021937B (zh) | 苯并噻唑甲酰胺类化合物及其应用 | |
EP3929182A1 (en) | Multi-target kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof | |
CN102036667B (zh) | 包含喹唑啉衍生物的组合物及其制备方法和应用 | |
CN102558159A (zh) | 4-取代间甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 | |
CN105566305B (zh) | 4-(取代苯胺基)喹唑啉衍生物二甲苯磺酸盐的多晶型物及其制备方法和用途 | |
CN102558160B (zh) | 4-取代对甲磺酰胺苯胺基-喹唑啉衍生物及其制备方法和用途 | |
CN101100466B (zh) | 不可逆蛋白质酪氨酸磷酰化酶抑制剂及其制备和应用 | |
CN102532103B (zh) | 喹唑啉芳基脲衍生物及其制备方法和用途 | |
CN103664890B (zh) | 喹啉衍生物的结晶及制备方法 | |
CN109988110A (zh) | 4-苯氧基喹啉并磺酰脲类化合物、合成该化合物的中间体及其制备方法和用途 | |
CN110028444A (zh) | 1-芳基-3-[4-(吡啶-2-基甲氧基)苯基]脲类化合物及应用 | |
CN102079759B (zh) | 6位取代的喹唑啉类衍生物、其制备方法和用途 | |
CN102093339B (zh) | 一类嘧啶衍生物的制备及用途 | |
CN102267952B (zh) | 喹唑啉类化合物、其制备方法和用途 | |
CN102532107B (zh) | 4-取代苯胺基-7-取代烷氧高哌嗪基-喹唑啉衍生物及其制备方法和用途 | |
CN109311845A (zh) | 酪氨酸蛋白激酶调节剂、晶型及其用途 | |
CN103073539B (zh) | 4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee after: Tianjin Institute of Pharmaceutical Research Co.,Ltd. Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: Tianjin Institute of Pharmaceutical Research |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190222 Address after: 300301 No. 308 Huiren Road, Binhai Science Park, Tianjin Binhai High-tech Zone Patentee after: NEW DRUGS EVALUATE Co.,Ltd. TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150923 Termination date: 20211220 |
|
CF01 | Termination of patent right due to non-payment of annual fee |